Scribe Therapeutics is a molecular engineering company focused on creating best-in-class in vivo therapies that permanently treat the underlying cause of disease. Founded by CRISPR inventors and leading molecular engineers Benjamin Oakes, Brett Staahl, David Savage, and Jennifer Doudna, Scribe is overcoming the limitations of current genome editing technologies by developing custom engineered enzymes and delivery modalities as part of a proprietary, evergreen CRISPR by Design™ platform for CRISPR-based genetic medicine.
We are seeking a highly creative, passionate, and motivated individual to join us in our quest to develop the next generation of CRISPR-based therapeutics. The current role is for a Process Engineer I to join our team and advance our platform.The candidate will join the Process Sciences Drug Substance team to contribute to and lead the development of key unit operations of mRNA CRISPR by Design™ platform processes. We seek enthusiastic, creative, and highly motivated individuals comfortable working in a fast-paced entrepreneurial CMC environment. Additionally, the candidate is expected to have a good understanding and strong knowledge of downstream process developm...
Scribe Therapeutics
A molecular engineering company developing best-in-class in vivo therapies using custom engineered enzymes and delivery modalities as part of a proprietary, evergreen CRISPR by Design™ platform for CRISPR-based genetic medicine
Other jobs at Scribe Therapeutics
Notifications about similar jobs
Get notifications to your inbox about new jobs that are similar to this one.
No spam. No ads. Unsubscribe anytime.
Similar jobs